Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $18,300 | 7 | 39.5% |
| Consulting Fee | $15,160 | 4 | 32.7% |
| Travel and Lodging | $11,496 | 31 | 24.8% |
| Food and Beverage | $1,340 | 24 | 2.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $44,795 | 65 | $0 (2019) |
| Nabriva Therapeutics, plc | $1,500 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $1,500 | 1 | Nabriva Therapeutics, plc ($1,500) |
| 2019 | $4,993 | 5 | Gilead Sciences, Inc. ($4,993) |
| 2018 | $32,923 | 46 | Gilead Sciences, Inc. ($32,923) |
| 2017 | $6,879 | 14 | Gilead Sciences Inc ($6,879) |
All Payment Transactions
66 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/19/2020 | Nabriva Therapeutics, plc | Xenleta (Drug) | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| Category: Antibiotic | ||||||
| 02/07/2019 | Gilead Sciences, Inc. | — | Consulting Fee | Cash or cash equivalent | $4,100.00 | General |
| 01/29/2019 | Gilead Sciences, Inc. | — | Travel and Lodging | In-kind items and services | $624.90 | General |
| 01/29/2019 | Gilead Sciences, Inc. | — | Travel and Lodging | In-kind items and services | $151.47 | General |
| 01/29/2019 | Gilead Sciences, Inc. | — | Travel and Lodging | In-kind items and services | $73.46 | General |
| 01/29/2019 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $43.48 | General |
| 10/18/2018 | Gilead Sciences, Inc. | Truvada (Drug) | Travel and Lodging | In-kind items and services | $20.00 | General |
| Category: HIV | ||||||
| 10/18/2018 | Gilead Sciences, Inc. | Truvada (Drug) | Food and Beverage | In-kind items and services | $4.61 | General |
| Category: HIV | ||||||
| 10/05/2018 | Gilead Sciences, Inc. | Truvada (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,060.00 | General |
| Category: HIV | ||||||
| 10/03/2018 | Gilead Sciences, Inc. | Truvada (Drug) | Travel and Lodging | In-kind items and services | $750.62 | General |
| Category: HIV | ||||||
| 10/03/2018 | Gilead Sciences, Inc. | Truvada (Drug) | Travel and Lodging | In-kind items and services | $303.40 | General |
| Category: HIV | ||||||
| 10/03/2018 | Gilead Sciences, Inc. | Truvada (Drug) | Travel and Lodging | In-kind items and services | $259.34 | General |
| Category: HIV | ||||||
| 10/03/2018 | Gilead Sciences, Inc. | Truvada (Drug) | Food and Beverage | In-kind items and services | $115.58 | General |
| Category: HIV | ||||||
| 09/14/2018 | Gilead Sciences, Inc. | Truvada (Drug) | Travel and Lodging | In-kind items and services | $20.00 | General |
| Category: HIV | ||||||
| 09/14/2018 | Gilead Sciences, Inc. | Truvada (Drug) | Food and Beverage | In-kind items and services | $8.69 | General |
| Category: HIV | ||||||
| 08/30/2018 | Gilead Sciences, Inc. | Truvada (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,060.00 | General |
| Category: HIV | ||||||
| 08/29/2018 | Gilead Sciences, Inc. | Truvada (Drug) | Travel and Lodging | In-kind items and services | $757.75 | General |
| Category: HIV | ||||||
| 08/29/2018 | Gilead Sciences, Inc. | Truvada (Drug) | Travel and Lodging | In-kind items and services | $304.40 | General |
| Category: HIV | ||||||
| 08/29/2018 | Gilead Sciences, Inc. | Truvada (Drug) | Travel and Lodging | In-kind items and services | $225.37 | General |
| Category: HIV | ||||||
| 08/29/2018 | Gilead Sciences, Inc. | Truvada (Drug) | Food and Beverage | In-kind items and services | $100.00 | General |
| Category: HIV | ||||||
| 08/03/2018 | Gilead Sciences, Inc. | Truvada (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,060.00 | General |
| Category: HIV | ||||||
| 08/03/2018 | Gilead Sciences, Inc. | Truvada (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,260.00 | General |
| Category: HIV | ||||||
| 07/30/2018 | Gilead Sciences, Inc. | Truvada (Drug) | Travel and Lodging | In-kind items and services | $40.00 | General |
| Category: HIV | ||||||
| 07/30/2018 | Gilead Sciences, Inc. | Truvada (Drug) | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: HIV | ||||||
| 07/25/2018 | Gilead Sciences, Inc. | Truvada (Drug) | Travel and Lodging | In-kind items and services | $1,244.79 | General |
| Category: HIV | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 1 | 17 | 22 | $3,322 | $1,271 |
| 2021 | 5 | 82 | 115 | $21,790 | $6,913 |
| 2020 | 3 | 49 | 77 | $13,067 | $3,643 |
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 17 | 22 | $3,322 | $1,271 | 38.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 26 | 51 | $9,384 | $2,875 | 30.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 17 | 21 | $3,171 | $1,339 | 42.2% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 12 | 12 | $4,668 | $1,281 | 27.5% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2021 | 16 | 18 | $3,150 | $829.68 | 26.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 11 | 13 | $1,417 | $586.96 | 41.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 17 | 32 | $5,888 | $1,831 | 31.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 17 | 29 | $4,379 | $1,382 | 31.6% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2020 | 15 | 16 | $2,800 | $429.49 | 15.3% |
About Dr. Ann Avery, MD
Dr. Ann Avery, MD is a Infectious Disease healthcare provider based in Cleveland, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1972528719.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ann Avery, MD has received a total of $46,295 in payments from pharmaceutical and medical device companies, with $1,500 received in 2020. These payments were reported across 66 transactions from 2 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($18,300).
As a Medicare-enrolled provider, Avery has provided services to 148 Medicare beneficiaries, totaling 214 services with total Medicare billing of $11,826. Data is available for 3 years (2020–2022), covering 9 distinct procedure/service records.
Practice Information
- Specialty Infectious Disease
- Location Cleveland, OH
- Active Since 07/13/2006
- Last Updated 12/22/2021
- Taxonomy Code 207RI0200X
- Entity Type Individual
- NPI Number 1972528719
Products in Payments
- Truvada (Drug) $38,734
- Xenleta (Drug) $1,500
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Cleveland
Steven Gordon, Md, MD
Infectious Disease — Payments: $161,172
Melissa Jenkins, Md, MD
Infectious Disease — Payments: $159,244
Grace Mccomsey, Md, MD
Infectious Disease — Payments: $125,254
Alan Jay Taege, Md, MD
Infectious Disease — Payments: $107,534
Dr. Robin Jump, Md, Phd, MD, PHD
Infectious Disease — Payments: $56,857
Dr. Robert Bonomo, Md, MD
Infectious Disease — Payments: $52,004